DNA - $44 Billion Buyout

07/21/2008 12:00 am EST


Thomas Aspray

, Professional Trader & Analyst

Roche's offer to buy remainder of Genetech (DNA) at $89 per share might explain the breakout on the weekly chart. This should give the market and biotech some support even though the price is not that much of a premium over last Friday's close.
  By clicking submit, you agree to our privacy policy & terms of service.

Related Articles on STOCKS

Keyword Image
All That JAZZ
12/11/2018 5:00 am EST

Jazz Pharmaceuticals (JAZZ). is the type of stock that should protect you in case of a bear market w...